Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6105)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2019 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hou H, Li WX, Cui X, Zhou DC, Zhang B, Geng XP. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate. World J Gastroenterol 2019; 25(36): 5483-5493 [PMID: 31576094 DOI: 10.3748/wjg.v25.i36.5483] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i36/5483.htm |
| Number | Citing Articles |
| 1 |
Juan Li, Lei Zheng, Rongmei Wang, Deqing Sun, Shuang Liang, Jing Wu, Yongqing Liu, Xiaona Tian, Tingting Li, Yang Yang, Leiqiang Han. <p>Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance</p>. International Journal of Nanomedicine 2020; : 5839 doi: 10.2147/IJN.S259432
|
| 2 |
Jinyue Wang, Hongyue Wang, Hongjia Xu, Jinghan Li, Xu Zhang, Xiangrong Zhang. Solid lipid nanoparticles as an effective sodium aescinate delivery system: formulation and anti-inflammatory activity. RSC Advances 2022; 12(11): 6583 doi: 10.1039/D1RA07638H
|
| 3 |
Meng Lu, Qin Xueying, Peng Hexiang, Gao Wenjing, Sara Hägg, Cao Weihua, Li Chunxiao, Yu Canqing, Lv Jun, Pang Zengchang, Cong Liming, Wang Hua, Wu Xianping, Wang Yunzhang, Li Liming. Genome-wide associations between alcohol consumption and blood DNA methylation: evidence from twin study. Epigenomics 2021; 13(12): 939 doi: 10.2217/epi-2021-0039
|
| 4 |
Ting-Yu Chang, Cheng-Tien Wu, Meei-Ling Sheu, Rong-Sen Yang, Shing-Hwa Liu. CARMA3 Promotes Colorectal Cancer Cell Motility and Cancer Stemness via YAP-Mediated NF-κB Activation. Cancers 2021; 13(23): 5946 doi: 10.3390/cancers13235946
|
| 5 |
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, Ali Mohammed Obayes, Zafar Aminov, Fahad Alsaikhan, Andrés Alexis Ramírez-Coronel, Pushpamala Ramaiah, Nahla A. Tayyib, Xuanming Luo. Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches. Environmental Research 2023; 228: 115767 doi: 10.1016/j.envres.2023.115767
|
| 6 |
Huiyong Zhao, Sheng Wei, Dachen Zhou, Yongfan Liu, Zicheng Guo, Chuibao Fang, Xiaoxi Pang, Fei Li, Hui Hou, Xiao Cui. Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1β/CXCL1 signalling pathway. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01424-y
|
| 7 |
Zhen Gui, Yan Zhang, Aihua Zhang, Weiwei Xia, Zhanjun Jia. CARMA3: A potential therapeutic target in non-cancer diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1057980
|
| 8 |
Xiao Cui, Huiyong Zhao, Sheng Wei, Qiang Du, Kun Dong, Yihe Yan, David. A Geller. Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages. Neoplasia 2023; 40: 100900 doi: 10.1016/j.neo.2023.100900
|